<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Of 498 patients with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL), 30 showed secondary central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) involvement </plain></SENT>
<SENT sid="1" pm="."><plain>Of these 30 patients, 26 had high-grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and 21 lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, mainly convoluted (n = 8) or Burkitt (n = 6) type according to the Kiel classification </plain></SENT>
<SENT sid="2" pm="."><plain>In half of the 30 patients, <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement was associated with progressive <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Bone marrow involvement was found in half of the patients before or at the time of the diagnosis of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement, which was 12 months (mean) after the diagnosis of NHL </plain></SENT>
<SENT sid="4" pm="."><plain>Eight patients received <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> prophylaxis </plain></SENT>
<SENT sid="5" pm="."><plain>Results of treatment for <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement are poor (mean survival time from <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement: 3.5 months) </plain></SENT>
<SENT sid="6" pm="."><plain>The Kiel classification allows good identification of patients at high risk of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:hpo ids='HP_0002665'>lymphoma</z:hpo>: systematic <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> prophylaxis is indicated only in the convoluted and Burkitt types </plain></SENT>
<SENT sid="7" pm="."><plain>An efficient prophylaxis must be found and results must be confirmed by other studies </plain></SENT>
</text></document>